Prevalence Of Protien Energy Malnutrition In Children With Chronic Renal Failure In Khartoum State by ABDO, HUSSIEN
 
University of Khartoum 
The Graduate College 
Medical and Health Studies Board 
 
 
 
PREVALENCE OF PROTIEN ENERGY MALNUTRITION 
IN CHILDREN WITH CHRONIC RENAL FAILURE IN 
KHARTOUM STATE 
                                                       A thesis 
 Submitted in the partial fulfillment of the degree of clinical MD in 
pediatrics and child health   
 
By 
DR.HUSSIEN ABDO BABIKER 
MB, BS University of Gezira 
 
Supervisor  
PROF. SALAH AHMED IBRAHIM 
MD, FRCP,FRCPCH  
Department of Paediatrics and Child health 
Faculty of Medicine 
U of K 
May 2007 
 
 
 i
 
 
 
 
 
Dedication 
To the soul of my father who 
encouraged me to attend the  
School of Medicine. 
To my mother who dedicated her life  
for me, my  
 brothers &  sister. 
To all those who supported me  
in this research. 
 
 
 
 
 
 
 
 
 
 ii
 
 
Acknowledgment 
 
Thanks to Almighty God. 
 I am most grateful to my supervisor Prof. Salah Ahmed Ibrahim for 
his guidance,supervision, valuable advice, support and encouragement 
throughout the study. 
 Special thanks to all patients of CRF and their parents. 
          Special thanks to my senior colleagues Dr. Mohamed Babiker for 
his valuable advices and support .  
        I would like also to express my thanks to Mr. Amin (Lab technician) 
who did the investigations; Mr. Hassan Ali for his meticulous statistical 
work , Mrs.Fadia A/Galil who typed the thesis and to the Sisters in Soba 
University Hospital, Bahri Renal Center and Dr. Salma  Renal Dialysis 
and Transplant Centre. 
 
 
 
 
 
 
 
 
 
 iii
Abstract 
 
 Malnutrition is one of the most important complication of 
CRF, it may lead to increased morbidity and mortality in children; 
and delay in physiological,, sexual and neurocognitive 
development. 
 This is across-sectional, hospital based study which was 
carried out during the period from Dec. 2005 to June 2006 at Dr. 
Selma Dialysis & Transplantation Center, Dialysis Unit of Soba 
University Hospital, Khartoum Teaching Hospital and Bahri Renal 
Center. 
 The aim of the study was to determine the prevalence of 
malnutrition and study the possible risk factors for development 
of malnutrition in children with CRF.  
          A total of 65 patients with CRF were studied .The mean age 
was 13.3 years (range 3.5 – 18 years); male patients were (n = 45) 
69.2%.  Eleven patients (16.9%) were diagnosed as CRF and 54 
(83.1%) were ESRD.  The cause of renal failure was undetermined 
in the majority of patients (n = 37) (56.9%) and most patients 
51(78.5%) were on HD.  
       The prevalence of malnutrition in the study group was found 
to be 67.7%. 
       The mean weight for age and height for age Z-scores 
distribution for patients with CRF were - 2.5 SD, - 2.8 SD 
respectively ,  and the larger number of children (n = 24) (36.9%) 
were moderately malnourished, 20 (30.8%) were severely 
 iv
malnourished and 16 (24%) were normal .This result was obtained 
by using Z-score height for age SD; while nearly the same result 
was obtained by using z-score weight for age SD. 
        In conclusion, malnutrition was found to be a common 
complication of CRF. The severity of malnutrition increased 
significantly with duration of dialysis (P < 0.017). Malnutrition 
was more associated with hemodialysis (P < 0.05) rather than 
peritoneal dialysis; further detailed studies were needed. 
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  ﻣﻠﺨﺺ  اﻷﻃﺮوﺣﺔ
ﻳﻌﺘﺒﺮ  ﺳﻮء اﻟﺘﻐﺬﻳﺔ اﻟﻤﺼﺎﺣﺐ ﻟﻤﺮﺿﻲ اﻟﻔﺸﻞ اﻟﻜﻠﻮي ﻣﻦ اﻟﻤﻀﺎﻋﻔﺎت اﻟﻬﺎﻣﺔ   
  وهﻮ ﻣﻦ اﻻﻣﺮاض اﻟﺘﻲ ﺗﺆﺛﺮ ﻋﻠﻲ اﻟﻨﻤﻮ -ﺔ واﻻﻣﺎﺗﻪ واﻟﺘﻲ ﻗﺪ ﺗﺘﺴﺒﺐ ﻓﻲ اﻻﻣﺮاﺿﻴ
  .اﻟﺠﻨﺴﻲ واﻟﻌﻘﻠﻲ 
 ﻃﻔﻞ ﻣﺮﻳﺾ ﺑﺎﻟﻔﺸﻞ اﻟﻜﻠﻮي ﻓﻲ اﻟﻔﺘﺮة ﻣﺎﺑﻴﻦ  56أﺟﺮﻳﺖ اﻟﺪراﺳﺔ ﻋﻠﻲ   
ﻣﺮآﺰ :   م وﻗﺪ ﺟﺎء اﻟﻤﺮﻳﺾ ﻣﻦ اﻟﻤﺎآﺰ اﻻﺗﻴﺔ6002 م وﺣﺘﻲ ﻳﻮﻧﻴﻮ 5002دﻳﺴﻤﺒﺮ 
 ﻣﺴﺘﺸﻔﻲ ﺳﻮﺑﺎ  وﺣﺪة ﻏﺴﻴﻞ اﻟﻜﻠﻲ ﺑﻜﻞ ﻣﻦ–اﻟﺪآﺘﻮرﻩ ﺳﻠﻤﻲ ﻟﻐﺴﻴﻞ وزراﻋﺔ اﻟﻜﻠﻲ 
  .اﻟﺠﺎﻣﻌﻲ وﻣﺴﺘﺸﻔﻲ اﻟﺨﺮﻃﻮم وﻣﺮآﺰ ﺑﺤﺮي ﻻﻣﺮاض وزراﻋﺔ اﻟﻜﻠﻲ 
اﻟﻬﺪف ﻣﻦ اﻟﺪراﺳﺔ هﻮ ﺗﺤﺪﻳﺪ ﻣﻌﺪل اﻧﺘﺸﺎر ﺳﻮء اﻟﺘﻐﺬﻳﺔ ﻋﻨﺪ اﻻﻃﻔﺎل اﻟﺬﻳﻦ   
  .ﻳﻌﺎﻧﻮن ﻣﻦ اﻟﻘﺼﻮر اﻟﻜﻠﻮي وآﺬﻟﻚ دراﺳﺔ اﻻﺳﺒﺎب اﻟﻤﺤﺘﻤﻠﺔ ﻟﺤﺪوث هﺬا اﻟﻤﺮض 
ام وﻧﺼﻒ وﺛﻤﺎﻧﻴﺔ ﻋﺸﺮ ﺗﺮاوﺣﺖ اﻋﻤﺎر اﻻﻃﻔﺎل اﻟﻤﺼﺎﺑﻴﻦ ﻣﺎﺑﻴﻦ ﺛﻼﺛﺔ اﻋﻮ  
ﻣﻦ اﻟﻌﺪد %  2.96ﻋﺎﻣﺎ ﺑﻤﺘﻮﺳﻂ ﺛﻼﺛﺔ ﻋﺸﺮ ﻋﺎﻣﺎ وﺛﻠﺐ وﻗﺪ ﺷﻜﻠﺖ ﻧﺴﺒﺔ اﻟﺬآﻮر 
وﻗﺪ آﺎﻧﺖ اآﺜﺮ % 1.38 آﺎﻧﺖ ﻧﺴﺒﺔ اﻻﻃﻔﺎل اﻟﻤﺼﺎﺑﻴﻦ ﺑﻔﺸﻞ آﻠﻮي ﻧﻬﺎﺋﻲ –اﻟﻜﻠﻲ 
ﻓﻴﻤﺎ ﺷﻜﻠﺖ ﻧﺴﺒﺔ اﻻﻃﻔﺎل اﻟﺬﻳﻦ % 9.65اﻻﺳﺒﺎب اﻟﻤﺆدﻳﺔ ﻟﻠﻔﺸﻞ اﻟﻜﻠﻮي ﻏﻴﺮ ﻣﻌﻠﻮﻣﺔ 
  % .5.87ﺼﻔﺎء اﻟﺪﻣﻮي ﻳﻌﺎﻟﺠﻮن ﻋﻦ ﻃﺮﻳﻖ اﻻﺳﺘ
آﺎن ﻣﺘﻮﺳﻂ ﻗﻴﺎس اﻟﻮزن ﻟﻠﻌﻤﺮ ﺑﺤﺴﺎب اﻻﻧﺤﺮاف اﻟﻤﻌﻴﺎري هﻮ ﻧﺎﻗﺺ اﺛﻨﻴﻦ   
  .  اﻧﺤﺮاف ﻣﻌﻴﺎرﻳﺎ 8.2 –ﺑﻴﻨﻤﺎ ﻣﺘﻮﺳﻂ ﻗﻴﺎس اﻟﻮزن ﺑﺎﻟﻨﺴﺒﺔ ﻟﻠﻄﻮل , وﻧﺼﻒ 
ﻣﻌﻈﻢ اﻻﻃﻔﺎل اﻟﺬﻳﻦ ﻳﻌﺎﻧﻮن ﻣﻦ اﻟﻔﺸﻞ اﻟﻜﻠﻮي اﻟﻤﺰﻣﻦ آﺎﻧﻮا ﻳﻌﺎﻧﻮن ﻣﻦ ﺳﻮء   
ﻣﻦ % 8.03ﻄﺮ ﺳﻮء اﻟﺘﻐﺬﻳﺔ اﻟﻮﺧﻴﻢ ﻋﻠﻲ ﺑﻴﻨﻤﺎ ﺳﻴ, % 9.63اﻟﺘﻐﺬﻳﺔ اﻟﻤﺘﻮﺳﻂ 
  .ﻣﻨﻬﻢ ﺣﺎﻟﺘﻬﻢ اﻟﺘﻐﺬوﻳﺔ ﻃﺒﻴﻌﻴﺔ % 42اﻟﻤﺮﺿﻲ وآﺎن 
آﻤﺎ , وﺟﺪ ان وﺧﺎﻣﺔ اﻟﻤﺮض ﻟﻬﺎ ﻋﻼﻗﺔ ﺑﺎﺳﺘﻤﺮارﻳﺔ اﻟﻤﺮض ﻓﻲ اﻻﺳﺘﺼﻔﺎء   
  .ﺗﺒﻴﻦ ان اﻻﺳﺘﺼﻔﺎء اﻟﺪﻣﻮي هﻮ ﺳﺒﺐ ﻣﺒﺎﺷﺮ ﻣﻦ أﺳﺒﺎب ﺣﺪوث ﺳﻮء اﻟﺘﻐﺬﻳﺔ 
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Chapter One 
 
1.1  Introduction and Literature Review 
 
 
Chronic renal failure (CRF) is defined as an irreversible and 
progressive reduction in the glomerular filtration rate (GFR) to below 
25% of the normal level (decline of 30 ml/min/1.73 m2) for at least three 
months.  Creatinine clearance (Ccr) is a good indicator of the GFR and 
is helpful in monitoring renal function of children in various age 
groups(1). 
CRF staged according to residual renal function into: 
• Impaired renal function:   40-80%. 
• Chronic renal insufficiency:  25 – 50%. 
• Chronic renal failure:   < 30%. 
• ESRD:  < 10%.  
 
CRF is characterized by progressive destruction of renal mass 
with irreversible sclerosis and loss of nephrones over a period of at least 
months to many years, depending on the underlying etiology (2).  
Regardless of the cause of kidney damage, once a critical level of renal 
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functional deterioration is reached, progression to end stage renal failure 
is inevitable(3).  
 
1.2       Classification of chronic renal failure 
1.2.1. Classification based on GFR, urinary and anatomic 
abnormalities: 
 In February 2002, the US National Kidney Foundation – Kidney 
disease quality initiative published a series of recommendations for 
identification and management of people with low GFR. 
 A classification system of CRF based on GFR, urinary and 
anatomic abnormalities is an integral part of this document. 
 US National Kidney Foundation K/DOQI classification of 
stages of CKD(4).  
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Table 1:1 Classification of chronic renal failure based on GFR 
Stage Description GFR in ml/min/1.73 
m2 
1 Kidney damage with normal or 
high GFR 
> 90 
2 Kidney damage with slightly 
low GFR 
60-89 
3 Moderate low GFR 30-59 
4 Severe low GFR 15-29 
5 Kidney failure < 15 
 
Source:    National kidney Foundations K/DOQI  
 
1.2.2. Classification based on residual renal function: 
 The currently accepted definitions are listed below based on the 
percentage of residual renal function and symptoms or metabolic 
abnormalities (5). 
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Table 1:2 Classification of Chronic Renal Failure based on residual renal 
function 
Stage Residual Renal Function Symptoms or Metabolic 
Abnormalities 
Impaired renal 
function (IRF) 
40-80 None 
Chronic renal 
insufficiency 
25-50 Asymptomatic, short 
stature,    PTH, etc.  
CRF <30 Acidosis, Anaemia,   BP 
lethargy  
ESRD Usually < 10 Dialysis is needed 
 
Source : Oskis Paediatrics,Principles and Practice,3rd ed. 
 
 The term impaired renal function refers to an individual who is 
asymptomatic and has renal function of 40% to 80% of normal.  The 
term CRI is associated with residual renal function of 25% to 50% of 
normal.  At this level of renal function, distinct biochemical 
abnormalities may present only when the patient is stressed.  
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 The term CRF is used to describe a patient who has residual renal 
function of less than 30%.  The patient with CRF exhibits biochemical 
abnormalities even when not stressed.  ESRD is a term reserved, when 
dialysis or transplantation is required; uremia is a symptom complex that 
includes anorexia, nausea, itching, neuropathy and malaise.  This 
complex is not associated with any special concentration of urea in the 
blood, but it usually is considered the last state of renal failure(5).  
1.3.   Prevalence And Magnitude of Malnutrition among 
C.R.F. Patients Worldwide: 
Malnutrition is recognized to be a serious and common 
complication of Chronic Kidney Disease (CKD) (6).  There is paucity of 
data regarding the prevalence and clinical consequences of Protein-
Energy Malnutrition (PEM) in the chronic renal failure, maintenance 
dialysis and renal transplant population in developing countries.  
Malnutrition, which is reported to be present in 42% to 77% of the end-
stage renal disease population in developing countries, is strongly 
associated with high morbidity and mortality.   Many religious practices 
in developing countries promote abstinence from meat, fish and eggs. 
Both vegetarian dietary pattern, which is being adopted by an increasing 
number of people, and ingestion of inadequate protein and calories in 
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the diet to arrest the progression of chronic renal failure, may lead to 
malnutrition(7). 
 
There is a high prevalence of protein-energy malnutrition in patients 
with chronic renal failure who are undergoing maintenance dialysis 
therapy. The high prevalence of malnutrition is a potentially serious 
problem because indices of protein-energy malnutrition are powerful 
predictors of mortality in maintenance dialysis patients. Although the 
data do not prove that improving nutritional intake will reduce 
mortality, nonrandomized studies suggest that provision of additional 
amino acids and energy to such patients is associated with reduced 
mortality(8).  There is a high prevalence of protein-energy malnutrition in 
both nondialyzed patients with advanced chronic renal failure and in 
those individuals with end-stage renal disease who are receiving 
maintenance hemodialysis or chronic peritoneal dialysis therapy. 
Approximately one-third of maintenance dialysis patients have mild to 
moderate protein-energy malnutrition, and about 6 to 8 percent of these 
individuals have severe malnutrition. These statistics are of major 
concern because markers of protein-energy malnutrition are strong 
predictors of morbidity and mortality(9).  
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 Most studies that have evaluated the nutritional status of patients 
with End Stage Renal Disease (ESRD) report some degree of 
malnutrition; in this population the prevalence have been estimated to 
range from 10% to 70% in patients undergoing hemodialysis and 18-51% 
in patients treated by continuous ambulatory peritoneal dialysis 
(CAPD).  Advanced malnutrition leads to muscle wasting and general 
debility but also precludes energy, non specific immune suppression, and 
poor wound healing.  .  Malnutrition is usually a chronic slowly 
progressive clinical syndrome but may accelerate rapidly with major 
recurrent illness or surgery(10,11).   
 In study carried out from Jan- March 2003 by Valenzuela RG 
and his colleagues, the nutritional condition in chronic renal failure 
patients treated by hemodialysis in Amazon was assessed, they 
concluded that the frequency of malnutrition is higher in their 
population, and the poor food intake may contribute to this condition (12). 
 In 2004 Anees M and colleagues evaluated the nutritional status 
of 51 patients of CRF on regular  hemodialysis, in Sheikh Zayed hospital 
Lahore, Pakistan, they found that the majority of patients were anemic, 
undernourished . Factors responsible for were economical, late referral 
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to nephrologists, inappropriate dietary restrictions, and inadequate 
dialysis (13). 
o In 2004 Majoned M, and colleagues studied the prevalence of 
malnutrition in dialysis patients.  They found that 20% of patients 
on CAPD and 13.2% on hemodialysis suffered from mild 
malnutrition (14). 
o Korupaiah T and others studied the anthropometric and growth 
assessment of children receiving Renal Replacement Therapy 
(RRT) in Malysia in across sectional study in 2002, found that 
pattern of growth and body composition appeared distinctly 
different with the different RRT modalities. Serial anthropometric 
evaluation appears vital in pre-and post-RRT monitoring in 
pediatric population with renal proplem (15). 
o In 2001 Zambon MP evaluated nutritional status of 41 children 
and teenagers with chronic renal failure using anthropometric 
measurement, concluded that the nutritional status from both 
muscle and fat stores were compromised(16). 
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1.4  Prevalence and Magnitude of Malnutrition in C.R.F in 
Sudan: 
o Dr Tamadur Elnur studied cardiovascular disease in children with 
chronic renal failure, the study consisted of 60 children with 
chronic renal failure aged 1.5 to 18 years.  She found that 
malnutrition was common in the study group (17). 
o In 1998 Dr. Amani Abdel Rahman, studied the clinical pattern 
and outcome of renal failure in Sudanese children in Khartoum 
State, the study consisted of 87 children with CRF aged one day 
up to sixteenth years, she found that there was significant 
reduction in the growth parameter of patients with CRF, those 
with acute renal failure were less affected (18).  
o Dr. Mohammed Babiker in 2004 revised the spectrum of renal 
bone disease in children with renal failure in Khartoum State.  He 
found that the mean height for age and weight for age Z-score 
distribution for patient with CRF was – 2.1 SD and the majority of 
children 22 (44.8%) out of 57 had moderate growth impairment (19). 
1.5  Morbidity and mortality: 
 A strong relationship has been shown between the extent of 
malnutrition and mortality in CRF patients.  Specifically, low serum 
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albumin levels appear to be independently associated with an increased 
risk of death in patients treated with hemodialysis(10,11), CAPD, and 
transplantation(20). Malnutrition is not limited to patients receiving renal 
replacement therapy.  There is evidence to suggest that the deteriorating 
nutritional status exists, even before initiation of dialysis and this has 
been shown to be a strong predictor of subsequent poor survival on 
dialysis(21,22)..  
 Several studies have documented that malnutrition and wasting 
are frequently observed in patients who have Chronic Renal Failure 
(CRF) with End Stage Renal Disease (ESRD) (23,24).  There is evidence 
that loss of lean body mass is associated with increased mortality and 
that also contributes to poor quality of life and rehabilitation(10,25,26).   
1.6  Causes of Protein energy malnutrition in C .R. F: 
            The causes of protein-energy malnutrition in patients with 
chronic renal failure include: (1) decreased energy or protein intake; (2) 
concurrent chronic illnesses, and superimposed acute illnesses and 
possibly increased inflammatory cytokines; (3) the catabolic stimulus of 
hemodialysis; (4) losses of nutrients into dialysate, particularly amino 
acids, peptides, protein (with peritoneal dialysis), glucose (when 
hemodialysis is performed with glucose-free dialysate) and water-soluble 
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vitamins; and (5) diagnostic or therapeutic (e.g., prednisone therapy) 
procedures that reduce nutrient intake or engender net protein 
breakdown. Other theoretically possible causes for protein-energy 
malnutrition include (6) chronic blood loss; (7) endocrine disorders 
(especially resistance to insulin and insulin-like growth factor-I, 
hyperglucagonemia, hyperparathyroidism and deficiency of 1,25-
dihydroxycholecalciferol); (8) products of metabolism that accumulate in 
renal failure and may induce wasting, such as organic and inorganic 
acids; (9) loss of the metabolic actions of the kidney; and (10) the 
accumulation of toxic compounds that are taken up from the 
environment (e.g., aluminum) (9). There are many causes for protein-
energy malnutrition in maintenance dialysis patients. Among the three 
most important factors are the nutritional status of the patient before 
commencing dialysis therapy, inadequate protein and energy intakes 
after they become dialysis patients, and acute and chronic illnesses. 
Improving the nutrient intake of maintenance dialysis patients is a 
challenging task because most chronic renal failure patients with 
malnutrition are anorectic, and dietary counseling has had limited 
success at increasing their nutrient intake. Other methods for improving 
nutritional status in adults, infants, and children with chronic renal 
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failure that have been tried with varying degrees of success include 
increasing the dose of dialysis and the use of food supplements and tube 
feeding. Less well-proven techniques for the treatment of protein-energy 
malnutrition include intradialytic parenteral nutrition. The use of 
appetite stimulants and such growth factors as rhGH and rhIGF-I are 
still in the experimental stage(8 ). 
 
 The cause of malnutrition in Chronic Terminal Kidney Failure 
are reviewed in the situation both before and after dialysis, as one the 
malnutrition has a high prevalence in terminal kidney patients, partly as 
a result of therapeutic restriction on calories and proteins, but also due to 
the metabolic reactions typical of the disease and to anorexia.  In 
patients subjected to dialytical methods, certain other mechanisms are 
added in addition to malnutrition, there are alterations in the metabolism 
of calcium, phosphorus and potassium, as well as lipids, thus limiting 
nutritional therapy’s ability to restore the nutritional status to normal (27).  
 The minimal protein intake required to maintain a neutral 
nitrogen balance in patients on chronic haemodialysis is almost two-
third higher than that required in pre-dialysis patients and in those 
without renal impairement(28,29).  Catabolic factors strictly related to 
hemodialysis treatment, such as loss of proteins and amino acids in the 
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dialysate, bio incompatible membranes, inflammation and metabolic 
acidosis, account for the higher needs of nutrient(30).  Inspite of the 
greater nutrient requirement, in these patients the protein-energy intake 
is often inadequate.  other important causes are anorexia, due to 
inadequate dialysis dose and/or secondary factors, such as underlying 
illness, anaemia, psychosocial conditions, loss of dentures and 
depression(31,32). 
 Lower nutrient intake in the face of higher requirements leads to 
malnutrition even in well-nourished and adequately dialysed 
patients(30,33).   
 In this regard, recent cross-sectional studies have suggested that 
the recommendation to minimize interdialytic weight gain, which is 
aimed at avoiding excessive sodium and fluid intake, can lead to a 
concurrent decrease of nutrition intake(27,34);  however, its potential 
impact on nutritional status remain unexplored.  On the other hand daily 
nutrient intake is variable, possibly decrease either on the dialysis day or 
during the interdialysis period(35,36);  nevertheless, whether a decrease of 
daily food intake can perse impair nutritional status is unknown(37). Why 
does malnutrition exist? 
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 Several factors related to the uremic state may contribute to the 
high incidence of protein-energy malnutrition in patients with CRF (22). 
 Inadequate nutrition intake is probably the most important single 
causes of malnutrition.  Studies that have looked at the protein and 
calorie intakes of patients on hemodialysis have often found that they fall 
far short of recommendations.  Reduction in nutrients intake starts in the 
predialysis period, with protein intake significantly reducing as renal 
failure progresses(38).  This observation reflects a spontaneous reduction 
in intake.  The use of protein restriction to slow the progression of CRF 
is an imposed restriction that is of concern to many as it may increase 
the risk of malnutrition. 
 An important factor in the reduction of intake is anorexia, a well 
known manifestation of CRF.  This may exist for a number of reasons: 
• Impaired acuity and diminished olfactory function have been 
described in patients with uraemia. 
• Inadequate dialysis and the use of acetate dialysate may induce 
nausea and anorexia and reduce intake; the dialysis dose above 
which nutrient intake will no longer improve as dialysis increases 
has not been defined. 
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• The presence of dialysate in the peritoneal cavity may interfere 
with gastric emptying and intestinal motility, possibly causing 
discomfort or pain. 
• Glucose obtaied from the dialysate may exert on inhibitory effect 
on food consumption. 
• Patients with CRF frequently have associated super imposed 
acute or chronic illness that may also reduce food intake, as can 
medications, autonomic gastroparesis (typically in diabetics but 
also seen in non diabetics ureamia), psychologic and socio-
economic factors(22). 
 Nutritional losses occur during treatment: 8-12 g aminoacids are 
lost per hemodialysis treatment; 5-15 g protein are lost daily during 
CAPD, which can increase to 30 g during episodes of CAPD 
peritonitis(22). 
 Protein catabolism may be induced by metabolic acidosis, which 
commonly accompanies progressive renal failure, periods of acute or 
chronic illness, and the use bioincompatible dialysis membranes, large 
doses of steroids used early in post transplant period, together with the 
stress of surgery, increase protein catabolism.  Patients who present for 
transplantation may already have pre-existing protein malnutrition and 
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this may be exaggerated when there is delayed graft function and 
continued dialysis endocrine disorders. 
 Endocrine disorders include insulin resistance, raised parathyroid 
hormone concentrations (which may promote amino acid catabolism 
and gluconeogenesis), and vitamin D deficiency (which may contribute 
to proximal myopathy) (22). 
 These are critical items as most cases of malnutrition in 
hemodialysis are of mild to moderate degree and not revealed by the 
common markers of nutrition(37). 
1.7 Evaluation of Nutritional Status in Children with 
Chronic Kidney Disease: 
A. End-stage renal disease: 
 The Kidney Disease Outcome Currently Initiative (K/DOQI) 
Clinical Practice Guidelines for Nutrition in Chronic Renal Failure (39) 
addresses the evaluation of protein-energy nutritional status for children 
receiving maintenance dialysis only.  No guidelines for pediatric patients 
with CRI before the onset of ESRD are available.  The dialysis 
guidelines emphasize that no single measures are recommended, with 
the implication that the treating team will integrate the results into           
a cogent assessment of nutritional status.  The recommended measures 
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include assessment of dietary intake, serum albumin a height or length 
(and SD score), estimated dry weight, weight/height index, skinfold 
thickness (sites not specified), mid arm circumference (MAC), and head 
circumference (for children aged < 3 years).  For children maintained on 
peritoneal dialysis,  the K/DOQI guidelines also suggest measurement 
of the protein equivalent of nitrogen appearance (40).  The protein 
equivalent of nitrogen appearance is used to estimate protein intake. 
B. Chronic renal insufficiency: 
 No guidelines exist for nutritional assessment of children with 
CRI.  However, there is ample evidence that even children with mild-to-
moderate CRI are at risk of growth retardation (41-43) and that growth 
linked to nutrient intake.  Common causes of CKD in children, such as 
obstructive uropathy and renal dysplasia, frequently result in salt wasting 
and acidosis even when renal function is relatively well preserved.  Salt 
wasting impairs growth (44); acidosis is associated with catabolic state and 
subnormal linear growth (45, 46).  Correction of these abnormalities has 
been shown to improve growth (44, 46).   
 In the absence of specific guidelines for the nutritional assessment 
of children with CRI, it is an opinion that the same measures 
recommended for children with ESRD be under taken with CRI, but less 
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frequently.  It is recommended that adults with a GFR < 60 ml. min-1 
.1.73 m-2 undergo evaluation of nutritional status at 6-12 mo intervals, 
and that this be increased to 1-3 mo interval when the GFR falls below 
30 ml min-1 .1.73 m-2 , or in the face of evidence of malnutrition (47).  
These GFR cutoffs and frequency of assessment are probably 
appropriate for most children with CRI as well.  However, growing, 
developing children may benefit from initiation of nutritional evaluation 
of a higher level of renal function and may require more frequent 
assessment.  Monitoring of nutritional status of intervals similar to those 
recommended for children with ESRD may be warranted in some 
children with CRI.  Infants in particular are at high risk of malnutrition 
and growth failure, which improve with nutritional supplementation 
(44,48-50).  Monthly nutritional evaluations may be beneficial in some 
infants with any degree of CRI. 
 Given that annual height, weight, and head circumference 
measurements are recommended even for healthy children, assessment 
of these 3 variables at 6- months intervals should be a minimum standard 
for children with moderate renal insult.  (GFR 30-59 ml .min-1 .1.73 m-2 ).  
Author believe that dietary assessment, weight/height index, or BMI-for-
age SD scores, triceps – skin fold thickness, and MAC would also be 
 19
useful in this group of children. However, until more data on the risk of 
malnutrition in the pediatric CRI population are available, these 
additional measures can be considered optional for these with moderate 
CRI. Author strongly recommended that all  the measure be undertaken 
in children with severe CRI (GFR 15-29 ml .min-1  ./. 73 m-2) and in all 
infants with CRI. 
1.8   Z-Score as Predictor of Malnutrition: 
 Measures of growth and nutritional status are often expressed as 
SD scores or Z scores.  SD scores are an alternative method of 
expressing percentiles; these 2 measures are interchangeable.  An SD 
score is the difference, in SD units, between an individual’s measure and 
the mean for children with the same characteristics.  For example, one 
could calculate a height SD score for age and sex by subtracting the 
mean height of a child of the same age and sex from the observed height 
and then dividing by the SD for children of that age and sex, this is not 
as simple as it appears.  Because both age and height are continuous 
variables, statistical manipulations are required to determine then mean 
and SD at every possible age.  Just as age increases smoothly, so too do 
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means and SDs for height.  In addition, the distribution of heights (or 
other measures) at any given age may not be normally distributed (51). 
1.9  The Effect of Dialysis on Nutritional Status: 
 Dialysis patients with malnutrition often have signs of 
inflammation, characterized by an increased in plasma C-Reactive 
Protein (CRP) and an imbalance between pre-inflammatory and anti-
inflammatory cytokines (52,53).  Markers of both malnutrition and 
inflammation predict mortality in dialysis patients, the majority of whom 
die from cardiovascular disease.  There is a close relationship between 
malnutrition, inflammation, and atherosclerosis in patients with renal 
disease.  It has been suggested recently that pre-inflammation cytokines 
represent a common link between malnutrition, inflammation, and 
atherosclerosis (MIA syndrome) in patients with chronic renal disease 
(52,53). 
 Therefore, it has been suggested that there may be at least two 
fundamentally different types of malnutrition in patients with CRI (53).   
The first is related to low protein and energy intake.  In this context, co-
morbid conditions are uncommon and serum albumin may be normal or 
only slightly decreased.  This type of malnutrition may be amenable to 
adequate nutritional and dialysis support. In contrast, the second type of 
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malnutrition is associated with inflammation and atherosclerotic 
cardiovascular disease (MIA syndrome).  Co-morbid conditions are 
common and serum albumin levels are usually decreased.  This type of 
malnutrition is much more difficult to reverse with nutritional support 
and dialysis therapy, unless the underlying co-morbid conditions and 
chronic inflammatory response are adequately treated (53).  Obviously, 
these two types of malnutrition are often combined in the clinical setting. 
 The cause of both malnutrition and inflammation are numerous 
in CRI patients with elevated serum level of CRP and pro- inflammatory 
cytokines.  Patients may not ingest sufficient amounts of food because of 
loss of appetite.  Anorexia can be caused by factors such as the retention 
of uraemic toxins and chronic metabolic acidosis, which, moreover, is an 
important catabolic factor.  In this regard inadequacy of dialysis 
treatment may be an “important cause of malnutrition.  Renal 
replacement therapy cause loss of nutrients.  
During a haemodialysis (HD) session, a considerable quantity of amino 
acids may be lost (4-9 g in the fasting state and 8-12 g post-prandially).  
In contrast, protein losses are negligible, unless multiple reuses of 
dialysis filters in practiced.  Peritoneal dialysis (PD) causes a loss of 
peptides, 90 of total protein and 6 g of albumin daily, and even much 
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more during episodes of peritonitis (54).  Both HD and PD can cause loss 
of vitamins, particularly water-soluble vitamins.  Endocrine and 
metabolic disturbances of uraemia, in particularly insulin resistance, can 
reduce protein anabolism and favor catabolism.  The role of 
psychological factors (depressen) and socio-economic factors (loneliness, 
invariety, poverty) should never be neglected, considering that at present 
the majority of the dialysis population is composed of elderly patients.  
Acute concurrent illness can also contribute to malnutrition.  Finally in 
adequate dietary prescription, due to traditional physician’s preference of 
prescribing nutritional restriction rather than providing nutritional 
counseling, can further worsen malnutrition. 
 The pathogenesis of chronic systemic inflammation in dialysis 
patients, which is associated with hypercatabolism and body wasting, is 
complex and not yet fully understood.  Serum IL-1, IL-6, and TNF 
levels are increased in patients with CRI already before the start of 
dialysis (55,56),  suggesting that renal failure perse is a contributing factor.  
Other non dialysis related causes of elevated CRP include co-morbid 
conditions, e.g. chronic heart failure with oedema (57) and the 
atherosclerosis process (58).  Moreover, various chronic infections, such as 
Chlamydia pneumonia (59) and dental or gingival infections may also 
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contribute.  Systemic inflammation due to infection can be of major 
importance in PD patients, due to recurrent peritonitis episodes and it is 
not negligible in HD patients, as infectious and sepsis are the second 
most common cause of death in this population.  Furthermore, it has 
been suggested that factors related to dialysis procedure itself may 
contribute to maintaining chronic systemic inflammation, e.g. bio-
incompatibility (60), the use of non sterile dialysate (61), and back-
filtration(62).  However, although HD with ultra-pure dialysate and 
biocompatible membranes is able to reduce serum CRP, it does not 
normalize it, reinforcing the importance of non-dialysis related factors in 
triggering the inflammatory response (63).   
             In the pathogenesis of malnutrition super imposed on conditions 
that result from uremia (23,24,64), nutritional problems caused by dialysis 
such as hemodialysis or Peritoneal Dialysis (PD), can play a major role.  
PD is a widely practiced ESRD treatment modality; more than 100,000 
patients throughout the word are currently being treated(65).  PD is based 
on the exchanges between blood and a glucose-containing peritoneal 
solution, thus exploiting the fluid and solute transport characteristics of 
the peritoneum.  Some major metabolic effects of PD can be caused by 
the absorption of glucose.  As much as 300 to 600 Kcal are provided 
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daily by different PD regimens and are responsible for the development 
of sustained hyper insulinaemia and the increase in triglycerides, as well 
as for the occurrence or aggrevation of atherosclerosis, which are 
observed after the initiation of this treatment(66).  
               Signs of protein energy malnutrition occur frequently in 
patients with chronic renal failure(67,68) protein energy malnutrition has 
been shown to be a major risk factor for increased morbidity and 
mortality in the chronic hemodialysis (CHD) patients(67,68).  Multiple 
factors predisposed (CHD) patients to protein energy malnutrition, e.g. 
low caloric intake, low protein intake, and the hemodialysis procedure 
itself, particularly, losses of amino acids or abnormal protein metabolism 
during hemodialysis might contribute to the observed protein energy 
malnutrition.  Studies examining the role of CHD itself on protein 
metabolism are limited(69).  Several lines indicate that CHD procedure 
can result in negative whole body protein balance.  Nitrogen balance has 
been shown to be more negative on a dialysis day compared with a 
nondialysis day, regardless of daily protein intake(70,71).  Lim et al(69) 
studied  whole body protein metabolism by applying the (C) leucine 
isotope dilution technique in fasting CHD patients during hemodialysis.  
They observed a reduction in whole body protein synthesis compared 
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with the predialysis period, and this resulted in a doubling of the 
negative protein balance already present in fasting CHD patients.  
furthermore, hemodialysis stimulates muscle protein losses compared 
with the predialysis period in fasting CHD patients (72). 
1.10  Effect of Low Serum Albumin on Nutritional status: 
 Hypoalbuminaemia is frequently seen in patients with CKD.  
More than 50% of the 1937 children with ESRD identified through the 
United States Renal Data System for a study of hypoalbuminaemia and 
mortality risk ,had serum albumin concentrations < 3.5 g/dL(6).  
Hypoalbuminaemia has been consistently shown to be associated with 
increased mortality in adults with CKD(73-75).  This association was also 
observed in children; each 1-g/dL decrease in serum albumin was 
associated with 54% higher risk of death(6).   
 Because protein-energy malnutrition is known to lead to 
hypoalbuminaemia, serum albumin is generally considered a useful 
index of nutritional status.  However as pointed out in the K/DOQI 
guidelines;  serum albumin is limited as marker of malnutrition status in 
the setting of CKD.   Serum albumin may be insensitive to acute change 
in nutritional status because of its long half-life.  In addition, serum 
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albumin is depressed in both in the setting of systemic inflammation and 
in volume-overload states (76,77). 
 Current evidence supports the existence of a “malnutrition – 
inflammation complex,” in which chronic inflammation leads to protein-
energy malnutrition (76,77). 
 Current evidence supports the existence of “malnutrition – 
inflammation complex”, in which chronic inflammation leads to protein-
energy malnutrition (76,78-80).  Although hypoalbuminaemia may indicate 
malnutrition without co-existence inflammation in some persons with 
CKD, hypoalbuminaemia in the absence of inflammatory markers is not 
predictive of increased mortality(81).  Serum albumin remains an 
important part of the general evaluation of patients with CKD, but its 
limitation as a marker of nutritional status must be recognized. 
 Like albumin, depressed serum prealbumin concentrations have 
been linked to increased mortality risk (82,83).  Prealbumin is not 
recommended for the nutritional assessment of pediatric patient with 
CKD, but its recommended in adults (84).  Although prealbumin has 
many of the same limitation as albumin, its half-life is much shorter:- 
2days, in contrast with 20days for albumin.  Therefore, it is more 
reflective of prevailing state.  However, prealbumin concentrations tend 
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to increase in the setting of renal dysfunction due to decreased clearance.  
The validity of prealbumin concentrations as a markers of nutritional 
status in the setting of CKD has not been established. 
1.11  Management of Malnutrition in C.R.F: 
Nutritional status should be monitored regularly in all children 
with (CKD), the best measures of nutritional status in children with 
CKD have not been established(73). 
Adequate nutritional status can perhaps be best defined as 
maintenance of normal pattern of growth and normal body composition 
by consumption of appropriate amounts and type of food(73). 
Nutritional status is particularly important in children, because it 
influences growth sexual development, and neurocognitive 
development(74,75). 
Consultation with dietitian should take place at least 3 times 
yearly and, in malnourished patient more often, as needed.  Dietetic 
documentation should include reports of food intake, subjective global 
assessment, anthropometric measurement, estimation of the serum 
albumin, and prealbumin, the serum lipid profile, sodium and potassium 
intake, calcium and phosphorus status, and any change in body weight(7). 
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         An awareness of energy expenditure in chronic terminal kidney 
failure and the consequences of malnutrition have lead to new challenges 
in nutritional therapy, both in the dose and quality of the proteins, with 
adebate ranging over the advantages of ketoanalogues, and also in 
method for repletion in oral administration , but this can be enhanced 
with artificial support such as oral supplements, parental nutrition during 
dialysis or such alternatives as enteral nutrition at home in the case of 
chronic kidney problems in children, using percutaneous endoscopic 
gastrostomy (PEG), in order to nourish the patients and minimize 
growth disorder(28).    
Certain general measures for prevention and treatment of uraemic 
malnutrition should be considered in all ESRD patients. Considering the 
catabolic nature associated with uraemia and chronic dialysis it is clear 
that ESRD patients should be continually encouraged to maintain 
adequate protein and caloric intake. Most of these patients tend to 
continue their predialysis diet while on chronic renal replacement 
therapy .It is therefore especially important to ensure that the protein and 
calorie intake of these patients meets the increased requirements of 
dialysis. 
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Frequent comprehensive dietary counseling by an experienced 
dietitian is important, as is detection of early sign of malnutrition.  
Similar efforts should be expended not only in out patients setting, 
but also when the patients are hospitalized, a setting in which these 
patients have ever lower protein and calorie intakes. 
Dietary counseling to improve nutritional status is limited in 
optimizing the dietary intake in certain subgroup of malnourished 
dialysis patients. For these patients, other forms of supplementation, 
such as enteral (including oral protein, amino acids, and energy 
supplementations, nasogastric tubes, percutaneous endoscopic 
gastroscopy, or jujunostomy tubes) and entradialytic parenteral nutrition 
(IDPN) must be considered. Several recents reports have recommended 
use of IDPN in malnourished chronic dialysis patients if enteral 
nutritional supplementation has not been effective. The early studies by 
Heidland and Kult, as well as several subsequent studies, reported 
positive effects of intradialytic infusion of nutrients on several nutrition 
al parameters (85) by contrast other studies were not able to show any 
benefits of IDPN , All of these studies had drawbacks in design and the 
choice of patient population. 
 
 30
Table 1.3:   Dietary needs of the chronic dialysis patient.  The recommended average 
levels of nutritional intake one depicted in table below and are similar to those 
recommended in the national renal diet (American Diabetic Association, 1993). 
Factor Non-uremic HD PD 
Protein (g/Kg) calories 0.8 1.2 1.2-1.5 
Sedentary (Kca1/Kg) 30 30 30-40 
Protein % 15-20 15 15 
Carbohydrate % 55-60 55-60 55-60 
Fat % 20-30 Balance Balance 
Cholesterol (mg) 300-400 300-400 300-400 
Poly unsaturated/ saturated fat 
ratio 
 
2.1: 1.0 
 
2.0: 1.0 
 
2.0: 1.0 
Crude fiber (g) 25 25 25 
Sodium (1g = 43mEq) 6-2 2g + 1g/LUO 2-4g + 1g/LUO 
Fluids (L/LUO) Adlib 1L + 1L/LUO 1.0-2.5L + 1L/LUO
Potassium (1g = 25mEq) 2-6 gm 2g + 1g/LUO 4g + 1g/LUO  
Calcium (g) 0.8-1.2 Diet + 1.2 Diet + 1.2 
Phosphorus (g) 1-1.8 6.6-1.2 6.6-1.2 
Magnesium (g) 0.35 0.2-0.3 0.2-0.3 
Iron (mg) 10-18 200mg/day 200mg/day 
Beta-carotene Non Non Non 
Vitamin A Non Non Non 
Retinol Non Non Non 
Thiamin (mg) 1.5 1.5 1.5 
Riboflavin (mg) 1.8 1.7 1.7 
Vitamin B6 (mg) 10 10 10 
Vitamin B12 (mg) 0.03 0.006 0.006 
Niacin (mg) 20 20 20 
Folic acid (mg) 1.0 > 1.0 > 1.0 
Source: Hand book of haemodialysis, 3rd ed. 
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1.11.1 Needs for individualization of the dietary prescription: 
Adherence to the renal diet is difficult and stressfull, due to the 
numerous restrictions of this type of diet. The diet for each patient 
should be individualized to help accommodate each patient's unique 
circumstance in terms of palatability, cost, co-morbid medical 
conditions, and cultural eating habits. Overly restrictive nutritional 
recommendations should be avoided as they may lead to poor intake. 
The nutritional recommendations that are provided by the 
dietitian need to be reinforced by other members of the health care team. 
Compliance with the diet should be assessed on a regular basis, often 
monthly at the initiation of dialysis or for those patients who have a 
history of non compliance with the renal diet. Patients additional dietary 
modifications. 
1.11.2   Adequacy of dialysis: 
The delivery of dialysis dose that is less than adequate, as defined 
by National Kidney Foundation Dialysis Oaf-comes Quality Initiatives 
(DOQI) guidelines results in the patient having a difficult time achieving 
the recommended level of protein and energy intake. It is suspected that 
the provision of adequate dialysis corrects subtle uraemia and thus 
enables patients to have less anorexia. 
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1.11.3   Protein management: 
Recommended levels of protein intake are designed to balance the 
protein anabolism and amino acid losses during dialysis with 
phosphorus restrictions that inherently limit protein intake. 
Hemodialysis patients DOQI guidelines recommend that 
hemodialysis patients should ingest 1.2 gm of protein per kilogram of 
average body weight per day. At least 50% of the protein ingested should 
be of high biologic values. This level of level of protein intake is often 
difficult to achieve in practice, however, with 30% to 50% of 
hemodialysis patients having a reported intake of less than 1.0 9 of 
protein per kilo gram of average body weight per day. 
Peritoneal dialysis patients: DOQI guidelines recommended that 
peritoneal dialysis patients should ingest 1.2 gm of protein per kilogram 
of average body weight per day. Some recommended that protein intake 
be as high as 1.5 9 of protein per kilo gram of average body weight per 
day for patients who are protein depleted. 
At least 50% of the protein ingested should be of a high biologic 
value. The higher level of protein recommended for peritoneal dialysis 
patients is designed to account for protein bases in the dialysate (86). 
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JUSTIFICATION 
 
 
? Nutritional complication in children with CRF and after 
transplantation, deserve regular clinical and nutritional monitoring 
in order to minimize later morbidity and mortality by appropriate 
treatment. 
 
? The malnutrition that complicates CRF and RRT are not well 
characterized in children in Sudan. Although many new centers 
and hospital were established in the last few years. 
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OBJECTIVES 
 
The objectives of the study is to: 
 
? determine the prevalence of malnutrition in children with chronic 
renal failure. 
 
? recognize the possible risk factors for developing malnutrition in 
children with chronic renal failure. 
 
? advice starting early nutritional management. 
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Chapter Two 
 
2-  PATIENTS AND METHODS 
 
2.1  Nature of the study:   
Cross sectional hospital based study. 
2.2  Study area:     
The study will be conducted on patients attending the following 
hospitals and renal centers in Khartoum state 
2.2.a Dr Selma Dialysis and Kidney Transplantation Center: 
       It was established in 1985 by Faculty of Medicine, University of 
Khartoum, as center for referral of patients with kidney disease, it now 
contains 17 hemodialysis machines (144 patients). 
      The pediatric division was established in 2002, serving as tertiary 
referral center.  
2.2.b Renal Unit, Soba University Hospital: 
A newly established unit located inside Soba University Hospital 
with a capacity of 8 HD machine .This center is specialized for 
Paediatric patients, it also includes a unit of peritoneal dialysis which 
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deals with both emergent and continuous ambulatory peritoneal 
dialysis(CAPD). 
2.2.c    Dialysis Unit Khartoum Teaching Hospital: 
      Acts with,  acapacity of 16 HD machines and 8 peritoneal dialysis 
beds (132patients) .There are only 6 children on regular HD . 
 2.2.d   Bahri Renal center: 
     It is located inside Khartoum North Teaching Hospital. It was 
established in May 2003 with acapacity of 10 HD machine (60patients) , 
15 of them are children with ESRD. 
2.3  Duration of the study: 
   Months from December 2005 to June 2006 according to the time 
frame shown (Table 2:1)  
Table 2:1: Time frame  
 
 
 
 
 
 
 
6th 5th 4th3rd2nd1st
 Final report 
 Draft report 
      Data entery&analysis 
      Data collection 
 Preparation 
Time per MonthsActivity 
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2.4  Study population: 
All children aged one month to 18 years who have chronic renal 
failure (GFR less than 50 ml/min) or (GFR less than 10ml /min) and 
maintained on dialysis, end stage renal failure were included. 
2.5 Case definitions:    
Chronic renal failure:     
Defined as an irreversible and progressive reduction in the GFR to 
below 25 % of normal level for at least three months.  ESRF is an 
irreversible and progressive reduction in the GFR to below 10 %. 
2.6  Sample size and sampling technique:  
2.6.1  Inclusion criteria:  
All children with CRF or ESRD below 18 years were included, 
after taking verbal consent from parents or caregiver. 
2.6.2  Exclusion criteria:     
Refusal to participate in the study. 
Children with known concomitant systemic disease e.g.(R.A) 
Children on dialysis due to other causes (ARF, poisoning etc). 
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2.6.3  Sample size: 
Since the international prevalence of chronic renal failure is very 
small and there is no prevalence from near by country a total coverage 
sample has been taken. 
This included all children presenting to the above mentioned 
hospitals and fulfilling the inclusion criteria,  The total number was 60 
patients during the period of study.   
2.7  Research tools and methods: 
2.7.1  Questionnaire for data collection that includes: 
• Personal data., social, dietary, dialysis and drug histories; diagnosis 
and cause of CRF. 
2.7.2  Anthropometry: 
 
Weight: older children were weighted in light clothing without shoes 
while infants were weighted undressed using infantometer. 
 The weight was measured to the nearest 0.1 kg. 
Supine Length: Recommended up to age of 2-3 years on a flat surface 
using infantometer. 
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 Standing Height: Taken without shoes ,with child standing with 
heels and back in contact with an upright wall using a height 
stadiometer.  The height was measured to the nearest 0.1 m. 
 Head circumferences: Measured using a non- stretchable 
measuring tape for children up to 2 years of age. 
 Mid upper arm circumference: Ensure measuring in same arm 
(non-   dominant) with a non stretchable measuring tape. 
 Body Mass Index: Wt (kg)/ Ht (meter2)  
 •    Children growth was determined using the national center for 
health statistic (NCHS-standards) specific reference standards as 
recommended by the WHO. Indices for height for age and weight for 
age were constructed and Z- Score were calculated using the cut off 
points which was considered as normal when Z-Score is more than -1 
SD ,Moderate when Z-score is less than -2.99 SD and Severe when Z-
Score is less than -3SD.s 
2.8  Clinical History and  Examination   
 Change in appetite. Gastrointestinal problems such as 
nausea, vomiting, diarrhea, constipation. In infants gagging, swallowing 
difficulties and inability to chew solids. 
 Thorough clinical examinations was done including: 
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a) Condition of hair, teeth, tongue, skin, and nail, eyes.  
 b) Impression of the preservation or wasting of fat or protein mass 
 c) Edema. 
 d) Blood pressure. 
2.8.1  Blood sampling: 
The following investigation was done to each subject: 
o Total protein 
o Serum albumin. 
o Hb. 
 
2.9  Research team:  
- Author select cases (completes the questionnaire, conduct full clinical 
examination, do anthropometric measurements and collect blood 
samples). 
One Lab technician.                                                                                            
One Statistician.                                              
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2.10  Statistics:  
   The data was entered into the computer and Statistical Package 
for Social Studies (SPSS) will be used for analysis. Analyzed data with 
95%.  P value <0.05 will be significant . 
            For anthropometric measurements (height for age, weight for 
age, and height for weight) a computer program (Epinfo V6) was used. 
 
2.11 Ethical considerations: 
  
- Informed verbal consent from patient, and parents will be 
obtained. 
- A letter will be issued for each unit which takes care of the 
patients explaining the project and ask for their kind acceptance 
and participation. 
- After diagnosis of any nutritional problem information will be 
given to each caring unit for further management. 
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Chapter Three 
3- Results 
 
During the period from December 2005 to June 2006, 65 
patients with chronic renal failure and/or end-stage renal failure were 
studied.  Eleven patients (16.9%) were diagnosed as CRF and 54 
(83.1%) were ESRF. 
3.1 Age distribution: 
The mean (+ SD) age of the study group was 13.3 (3.2) yrs 
(range: 3.5 – 18 yrs).  The age distribution of children in the study 
group is shown in Figure.1 
3.2 Gender distribution: 
Male patients constituted (n = 45) 69.2%  while females were 20 
(30.8%).  See Figure 2. 
3.3 Distribution of patients by region:  This is shown in (Figure 3). 
3.4 Ethnic groups: 
Thirty eight patients (58.5%) were from Arab Ethnic 
background, 14 (21.5%) were from Afro-Arab ethnic background, and 
13 (20%) were African.  (Figure   4) 
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3.5 Distribution of cases by residence: 
 Most of the patients 40 (61.5%) were from urban areas, 16 
(24.6%) were from rural areas and 9 (13.8%) were from suburban 
areas around the capital.   (Figure  5) 
3.6 School performance and attendance of  cases:   
a) Before diagnosis of  renal failure: 
The majority of children 50 (90.8%) were regularly attending 
school before the illness.  Those with excellent performance were 34 
(52.3%), good 16 (24.6%); whereas 7 (10.8%) had fair and 2 (3.1%) 
had poor school performance.  Only 6 (9.2%) children did not enter 
the school.  (Figure 6.a) 
b) After illness: 
Most of the children 22 (39.8%) irregularly attended the school 
after the illness, 19 (29.2%) left the school and only 18 (27.7%) still 
regularly attend the school. (Figure 6.b) 
3.7 Classification of cases of CRF according to severity: 
The majority of patients [n =54 (83.1%)] had ESRD, while 6 
(9.2%) had moderate CRF, 4 (6.2%) had severe CRF, and only 1 
(1.5%) patient had mild CRF.    (Table 3:1) 
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Table 3.1:  Classification of the cases of CRF according to severity 
 
Classification Number Percentage 
Mild CRF 1 1.5 
Moderate CRF 6 9.2 
Severe CRF 4 6.2 
ESRD 54 83.1 
Total 65 100.0 
 
CRF = Chronic Renal Failure 
ESRF = End Stage Renal Failure 
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3.7.1 Serum creatinine: 
The mean (+ SD) serum creatinine level for the study group is 
7.1 (3.2) mg/dl SD, (range: 1.1 to 14.4 mg/dl). 
3.7.2 Glomerular filtration rate: 
The mean (+SD) GFR for the study group is 11.96 (10.9) 
ml/min/1.73, (range: 3.4 to 69.3 ml/min/1.73m2). 
3.7.3 Etiology of CRF: 
The cause of renal failure was uncertain in 37 (56.9%) patients 
while glomerulnephritis was the cause of renal failure in 10 (15.4%) 
patients.  Obstructive uropathy was responsible for CRF in 9 (13.8%) 
patients while 5 (9.2%) patients had cystic/heridatroy/congenital 
causes.  Hemolytic uraemic syndrome caused CRF in 2 (3%) patients 
and one (1.5%) patient had Alport syndrome. (See Table 3.2) 
3.7.4 Treatment modality: 
Most of the patients 51 (78.5%) were on HD, 3 (4.6%) were on 
Continuous Ambulatory Peritoneal Dialysis (CAPD) and 11 (16.9%) 
were on conservative management. ( Figure 7) 
3.7.5 Duration of CRF: 
The mean (+ SD) duration of diagnosis of renal failure is 2.36  
(2.5) years (range: 1 week to 8 years). 
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Table 3.2:  Causes of CRF among the study group 
 
Cause Number Percentage 
Unknown 37 56.9 
Glomerulonephritis 10 15.4 
Obstructive uropathy 9 13.9 
Cystic/hereditary/congenital 6 9.3 
HUS 2  3.0 
Alport syndrome  1 1.5 
Total 65 100.0 
 
HUS =Hemolytic Uraemic Syndrome 
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3.7.6 Duration on dialysis: 
The mean (+ SD) duration on dialysis was 13.0  (16.8) months 
(range < 1 to 48 months). 
3.8 Past Medical History: 
3.8.1 History of hospitalization 
Sixty one (93.8%) patients were previously admitted to 
hospital because of illnesses, most of them admitted once 26 (42.6%), 
10(16.4%) have admitted twice, and 25 (41%) admitted more than 
two times (Figure 8) 
3.8.2 Blood transfusion: 
Fifty four (83.1%) patients received blood transfusion; those 
who received blood once, twice and more than two times  were 10 
(18.5%), 12 ( 22.2%) and 32 (59.3%), respectively. (Figure   9)  
3.9 Symptoms and signs: 
3.9.1 Symptoms of malnutrition: 
The commonest presentation was weight loss in 37 (56.9%) 
patients.  Anorexia was found in 28 (43.1%).  9 (13.8%) cases had LL 
swelling while 7 (10.8%) presented with night blindness and skin 
pigmentation was observed in 2 (3.1%) cases.  (Figure 10) 
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3.9.2 Symptoms of anemia: 
Twenty six (40.0%) patients suffer from fatigability, while 14 
(21.5%) presented with palpitation, 9 (13.8%) with cough and 5 
(7.7%) with of shortness of breath.  (Figure 11) 
3.9.3 Signs of Malnutrition: 
Nine (13.8%) patients had wasting; skin changes occurred in 4 
(6.2%) while koilonychia as well as dental carees were observed in 3 
(4.6%) cases. (Figure 12).  No patient had acidotic breathing.  
3.9.4 Height for age group: 
The mean (+ SD) Z-score height for age for the study group 
was - 2.1  (1.7). (range 6.5 – 0.33). 
3.9.5 Weight for age group: 
The mean (+ SD) Z-score weight for age for the study group 
population was - 2.5 (3.2).  (range - 4.8 – 4.2). 
3.9.6 Weight for height group: 
The mean (+ SD) Z-score weight for age for the study group 
was - 2.1 (1.2).  (range - 2.8 – 0.9). 
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3.9.7   Nutritional assessment: 
According to Z-score height for age of the study group, 24 
(36.9%) of patients were found to be moderately malnourished; 20 
(30.8%) were severely malnourished  and 16 (24.6%) were normal.   
(Table 3.3) 
Nearly the same result was found when using Z score weight 
for age; 42 (64.6%) patients were moderately malnourished, 14 
(21.5%) were severely malnourished and 4 (6.2%) were normal.  
(Table 3. 4) 
3.10 Dietary Restriction: 
Protein restriction was observed in 22 (33.8%) patients while 43 
(66.2%) did not restrict protein from their diet  (Figure 13).  Twenty 
one (32.3%) patients balanced their fluid intake while 44 (67.7%) took  
fluid freely. 
3.11 Anthropometric Measurements: 
3.11.1 Weight: 
The mean (+ SD) weight for the study group was 30.7 (9.9) 
kg(range: 9 kg and 53 kg). 
3.11.2 Height: 
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The mean (+ SD) height for the study group was 141.1 (18.6) 
cm (range: 76 cm – 174.5 cm). 
Table 3.3: Z-score height for age of the study group 
(n = 60)* 
Nutritional status Number Percentage  
Severe 20 30.8 
Moderate 24 36.9 
Normal 16 24.6 
Total 60 92.3 
 
* Five patients aged 18 years Z-scores height and weight for age 
could not be applied statistically. 
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Table 3.4: Z-score weight for age of the study group 
(n = 60)* 
Nutritional status Number Percentage  
Severe 14 21.5 
Moderate 42 64.6 
Normal 04 06.2 
Total 60 92.3 
 
* In five patients aged 18 years Z-scores height and weight for 
age could not be applied statistically. 
 
 
 
 
 
 
 
 
 65
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 66
 
 
3.11.3 Surface area: 
The mean (+ SD) surface area for the study group was 1.1 
(0.3) m2   (range 0.26 – 1.55 m2). 
3.11.4 Skin Fold Thickness (SFT): 
The mean (+ SD) SFT for the study group 5.3 (0.4) mm 
ranging from 0.62 mm to 18 mm. 
3.11.5 Mid Upper Arm Circumference (MUAC): 
The mean MUAC for the study group 18.9 (3.1) cm   ranging 
from (12.0 to 31 cm). 
3.12 Investigations: 
3.12.1 Hemoglobin level: 
In the majority 57 (87.6%) of patients, the mean (+ SD) 
hemoglobin level was 8.2  (2.1)  g/dl (range: 14 to 12.6 g/dl). 
3.12.2 Serum albumin: 
Most of patients  41 (63.1%)had normal serum albumin.  The 
mean (+ SD) serum albumin for the study group was 3.7 (6.7) g/dl 
(range: 2.1 – 5.1gm/dl). 
3.12.3 Total protein: 
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The total serum proteins were found to be normal in 52 (80%) 
patients.  Mean (+ SD) total protein was 7.3 (1) g/dl. (range 5.2 – 9.5 
g/dl). 
3.13 Malnutrition and Type of Dialysis: 
 Using Z-score height for age, out of 20 severely malnourished 
seventeen (85.0%) were on hemodialysis and 21 (87.5%) out of 24 
moderately malnourished were commencing hemodialysis.  This is 
statistically significant.  P < 0.50 (Table 3.5)   
 The same result was obtained when using Z-score weight for 
age, most of the severely malnourished child 12 (85.7%) were on 
hemodialysis, and of that 42 moderately malnourished 32 (76.2%) 
were also commencing hemodialysis which is not significant.  P = 
0.382.  (Table 3.6)  
3.14    Malnutrition and duration on dialysis: 
 Using Z-score height for age, most 9(52.9%) of the severely 
malnourished children were on regular dialysis for 2-4 years, while 
most 17(77.3%) of the moderately malnourished children were on 
regular dialysis for less than 2 yrs which is statistically significant. (P 
< 0.017).  (Table 3.7) 
 When using z-score weight for age, half of the severely 
malnourished children 6(50%) were on dialysis for a period of less 
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than 2 years while most of the moderately malnourished 26 (74.3%) 
were also on dialysis for a period less than two years which is not 
statistically significant.  (P = 0.238).  (Table 3.8) 
 
Table 3.5:   Z-score height for age and type of treatment  
 
 
 PD  =   Peritoneal Dialysis 
 PEM  = Protein Energy Malnutrition 
P < 0.050 
 
 
Type of treatment Nutritional status 
 Severe  
PEM 
Moderate 
PEM 
Normal 
 n % n % n % 
Cases on PD 0 0.0 1 4.2 2 12.5 
Cases on HD 17 85.0 21 87.5 8 50.0 
Cases on conservative 
therapy 
3 15.0 2 8.3 6 37.5 
Total 20 100.0 24 100.0 16 100.0 
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Table 3.6:   Z-score weight for age and type of treatment 
  
 
 
 
 
 
 
 
 
 PD  = Peritoneal Dialysis 
 HD  = Hemodialysis  
 PEM = Protein Energy Malnutrition 
P = 0.382 
 
Type of 
treatment 
Nutritional status 
 Severe  
PEM 
Moderate 
PEM 
Normal 
 n % n % n % 
PD 0 0 3 7.1 0 0 
HD 12 85.7 32 76.2 2 50.0 
Conservative 2 14.3 7 16.7 2 50 
Total 14 100.0 42 100.0 4 100.0 
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Table 3.7: Z-score height for age and duration of dialysis: 
 
 PEM =   Protein Energy of Malnutrition 
P < 0.017 
 
 
 
 
 
Duration of dialysis 
(Years) 
Nutritional status 
 Severe  
PEM 
Moderate 
PEM 
Normal 
 n % n % n % 
0 - 2 7 41.2 17 77.3 10 100.0 
2 - 4 9 52.9 5 22.7 0.0 0.0 
> 4 1 5.9 0 0.0 0.0 0.0 
Total 17 100.0 22 100.0 10 100.0 
 71
 
 
 
 
Table 3.8:   Z-score weight for age and duration of dialysis: 
 
 
 PEM = Protein Energy Malnutrition 
P < 0.017 
 
 
  
Duration of dialysis 
(Years) 
Nutritional status 
 Severe  
PEM 
Moderate 
PEM 
Normal 
 n % n % n % 
0 - 2 6 50.0 26 74.3 2 100.0 
2 - 4 5 41.7 9 25.7 0 0.0 
> 4 1 8.3 0 0.0 0 0.0 
Total 12 100.0 35 100.0 2 100.0 
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3.15    Malnutrition and severity of CRF: 
 According to Z-score height for age, out of 20 severely 
malnourished 17 (85%) had ESRD, 1 (5%) had severe CRF and 2 
(10%) had moderate CRF; and out of 24 moderately malnourished 22 
(19.7%) had ESRD, 1 (4.2%) had severe CRF and 1 (4.2%) had 
moderate CRF.  This is statistically not significant. (P = 0.325) (Table 
3.9) 
 Nearly the same result was obtained when using Z-score. 
weight for age; out of 14 severely malnourished patients, 11 (78.6%) 
had ESRD, 1 (5.0%) had severe CRF and 2 (10.0%) had moderate 
CRF; and of those 42 moderately malnourished 35 (83.3%) had 
ESRD, 2 (4.8%) had severe CRF, 4 (9.5%) had moderate CRF and 
only 1 (2.4%) patient had moderate CRF.  This is statistically 
significant,   (P < 0.05).  (Table 3.10) 
3.16    Malnutrition and Income per month: 
 According to z-score height for age, 8 (40%) of severely 
malnourished children had very low income, 7 (35%) had low 
income, while 1 (5%) had moderate income and 4 (20%) had good 
income.  While 8 (33.3%) of moderately malnourished had very low 
income and the same number had low income, 7 (29.2%) had                                        
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Table 3.9: Z-score height for age and classification of CRF 
 
Nutritional    
status 
Mild 
CRF 
Moderate 
CRF 
Severe 
CRF 
ESRD Total 
 n % n % n % n % n % 
Severe PEM - - 2 10 1 5 17 85 20 100.0 
Moderate PEM - - 1 4.2 1 4.2 22 91.7 24 100.0 
Normal  1 6.2 3 18.8 2 12.5 10 62.5 16 100.0 
 
 CRF  = Chronic Renal Failure 
ESRD = End Stage Renal Disease  
 
P = 0.325 
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Table 3.10: Z-score weight for age and classification CRF 
 
Degree of 
malnutrition 
Mild 
CRF 
Moderate 
CRF 
Severe 
CRF 
ESRD Total 
  n % n % n % n % n % 
Severe PEM - - 2 14.3 1 7.1 11 78.6 14 100.0 
Moderate PEM 1 2.4 4 9.5 2 4.8 35 83.3 42 100.0 
Normal  0 0.0 0 0.0 1 25 3 75 4 100.0 
 
CRF  = Chronic Renal Failure   
ESRD = End Stage Renal Disease  
PEM  = Protein Energy Malnutrition 
P = 0.758 
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moderate income and only 1 (4.2%) had good income.  P = 0.199. 
which is not significant.  (Table 3.11) 
Using Z-Score weight for age 3(21.4%) of severely 
malnourished had very low income, 7(50%) had low income, 
2(14.3%) had good income. While 19(45.2%) of moderately 
malnourished had very low income, 10(23.8%) had low income, 
8(19%) had moderate income and 5(11.9%) had good income.  P 
value = 0.378, not statistically significant.   (Table 3.12) 
3.17   Malnutrition and proteins restriction  
Using Z-score height for age 21 patients restricted proteins of 
their diet, 9 (42.9%) of them had severe malnutrition, while 5 (23.8%) 
patients were moderately malnourished and 7 (33.3%) patients were 
normal. 
 Of those 39 patients who took proteins freely, 11 (28.2%) were 
severely malnourished, while 19 (48.7%) patients were moderately 
malnourished and 9 (56.3%) were normal.  P value = 0.171,not 
significant .  (Table 3.1 When using Z-score weight for age, out 
of 21 patients whom restricted proteins of their diet, 5 (23.8%) were 
severely malnourished, 12 (57.1%) were moderately malnourished 
and 4 (19%) were normal, those who had no restriction of protein in 
their diet were 39 patients,  
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Table  3.11:   Z-score height for age and income per month of the 
study group 
Nutritional 
status 
V. low Low Moderate Good Total 
 n % n % n % n % n % 
Severe  PEM 8 40 7 35 1 5 4 20 20 100.0 
Moderate PEM 8 33.3 8 33.3 7 29.2 1 4.2 24 100.0 
Normal 9 56.3 3 18.8 2 12.5 2 12.5  16  100.0 
 
PEM  = Protein Energy Malnutrition  
                                            P  = 0.199  
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Table 3.12:   Z-Score weight for age and income per month of the 
study group: 
 
Degree of 
malnutrition 
V. low Low Moderate Good Total 
 n % n % n % n % n % 
Severe PEM 3 21.4 7 50 2 14.3 2 14.3  14  100.0 
Moderate PEM 19 45.2 10 23.8  8 19  5 12.0  42 100.0 
Normal 3 75 1 25 0 0.0 0 0.0  4  100.0 
 
PEM = Protein Energy Malnutrition 
 
                                                    P =   0.378  
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Table 3.13: Z-score height for age and protein restriction of the 
study group 
 
Nutritional status Protein 
restriction 
No protein 
restriction 
  n  % n % 
Severe PEM 9 42.9 11 28.2 
Moderate PEM 5 23.8 19 48.7 
Normal 7 33.3 9 23.1 
Total 21 100.0 39 100.0 
 
PEM  =  Protein Energy Malnutrition 
 
P = 0. 171 
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30 (76.9%) of them were moderately malnourished and 9 (23.1%) of 
them were severely malnourished and this is statistically significant.  
(P < 0.017) .  (Table 3.14) 
3.18   Malnutrition and Previous Hospitalization 
 Using z-score height for age;   23 (41.1%) of previously 
admitted patients were moderately malnourished, while those 
severely malnourished were 19 (33.9%) and the normal were 14 
(25%).  P = 0.547.  (Table 3.15) 
 The same result was obtained when using z-score weight for 
age, most of the previously admitted 39 (69.6%) patients were 
moderately malnourished, 13 (23.2%) patients were severely 
malnourished and 4 (7.1%) patients were normal. P = 0.858. 
Statistically not significant.  (Table 3.16) 
3.19    Malnutrition and Blood Transfusion: 
 According to z-score height for age, 20(40.80%) of patients 
who received blood transfusion were moderately malnourished, 18 
(36.7) were severely malnourished and 11 (22.4%) were normal.  P = 
0.252.  Statistically is not significant.  (Table 3.17) 
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Table 3.14: Z-score weight for age and protein restriction of the 
study group 
 
Nutritional 
status 
 Protein 
restriction 
No Protein 
restriction 
  n % n % 
Severe PEM 5 23.8 9 23.1 
Moderate PEM 12 57.2 30 76.9 
Normal 4 19.0 0 0 
Total 21 100.0 39 100.0 
 
PEM =  Protein Energy Malnutrition 
 
P < 0.017 
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Table 3.15: Z-score height for age and previous hospitalization of 
the study group 
 
Nutritional 
Status 
 Previous 
hospitalization 
No Previous 
hospitalization 
 N  % n % 
Severe  PEM 19 33.9 1 25 
Moderate PEM  23 41.1 1 25 
Normal 14 25.0 2 50 
Total 56 100.0 4 100.0 
 
PEM = Protein Energy Malnutrition 
 
P = 0.547 
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Table 3.16: Z-score weight for age and previous hospitalization of 
the study group 
 
Nutritional 
Status 
Previous 
hospitalization 
No Previous 
hospitalization 
 n  % n % 
Severe PEM 13 23.2 1 25 
Moderate PEM 39 69.6 3 75 
Normal 4 7.1 0 0 
Total 56 100.0 4 100.0 
 
 
P = 0.858 
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Table 3.17: Z-score height for age and blood transfusion of the 
study group 
 
Nutritional 
status 
 Blood       
transfusion 
No Blood 
transfusion 
 n % n % 
Severe PEM 18 36.7 2 18.2 
Moderate PEM 20 40.8 4 36.4 
Normal 11 22.4 5 45.5 
Total 49 100.0 11 100.0 
 
PEM = Protein Energy Malnutrition 
 
P = 0.252 
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The same result was obtained when using Z-score weight for age the 
bulk of the transfused patient were moderately malnourished 35 
(71.4%), 11 (22.4%) were severely malnourished and 3 (6.1%) were 
normal. P = 0.867. Statistically is not significant.   (Table 3.18) 
3.20   Malnutrition and Serum Total Protein 
 Using Z-score height for age, most of severely malnourished 
14 (70%) patients had normal serum protein, as well as those of 
moderate malnutrition.  20 (83.3%) patients had also normal serum 
protein. P = 0.535, not statistically significant (Table 3.19) 
 The same result was obtained when using Z-score.  
Weight for age the bulk of the severely malnourished 12 (85.7%) had 
normal serum protein, and most of the moderately malnourished 33 
(78.6%) had also normal serum protein’s. P = 0.310 , not statically 
significant.  (Table 3.20) 
3.21   Malnutrition and Serum Albumin 
 According to Z-score height for age, almost half of the severely 
malnourished patient had normal serum albumin, while most of the 
moderately malnourished 15 (62.5%) had normal serum albumin.  (P 
= 0.697) Statistically is not significant.  .  (Table 3.21) 
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Table 3.18: Z-score weight for age and blood transfusion of the 
study group 
 
Nutritional 
status 
 Blood      
transfusion 
No Blood 
transfusion 
 n % n % 
Severe 11 22.4 3 27.3 
Moderate 35 71.4 7 63.6 
Normal 3 6.2 1 9.1 
Total 49 100.0 11 100.0 
 
P = 0.867 
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Table 3.19: Z-score height for age and serum protein of the study 
group 
 
 
Nutritional 
status 
Normal serum 
protein 
Low serum  
protein 
Total 
 n % n % n % 
Severe 6 30 14 70 20 100.0 
Moderate 4 16.7 20 83.3 24 100.0 
Normal 3 18.8 13 81.3 16 100.0 
 
P = 0.535 
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Table 3.20: Z-score weight for age and serum protein of the study 
group 
 
 
Nutritional 
status 
Normal serum 
protein 
Low serum protein Total 
 n % n % n % 
Severe PEM 2 14.3 12 85.7 14 100.0 
Moderate PEM 9 21.4 33 78.6 42 100.0 
Normal 2 50 2 50 4 100.0 
 
P = 0.310 
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Table 3.21: Z-score height for age and serum albumin of the study 
group 
  
  
Nutritional 
status 
Normal serum 
albumin 
Low serum 
albumin 
Total 
 n % n % n % 
Severe PEM 9 45 11 55 14 100.0 
Moderate PEM 9 37.5 15 62.5 42 100.0 
Normal 5 31.3 11 68.8 4 100.0 
 
P =  0.697  
 
 
 
 
 
 
 
 
 89
Using Z-score weight for age, most of severely and moderately 
malnourished 10 (71.4%), 25 (59.5%) respectively, had low serum 
albumin.  P = 0.645 which is statistically not significant.  (Table 3.22) 
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Table 3.22: Z-score weight for age and serum albumin of the study 
group 
 
  
Nutritional 
status 
Normal  serum 
albumin 
Low  Serum 
albumin 
Total 
 n % n % n % 
Severe PEM 4 28.6 10 71.4 14 100.0 
Moderate PEM 17 40.5 25 59.5 42 100.0 
Normal 2 50 2 50 4 100.0 
 
P = 0.645 
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Chapter Four 
 
4- DISCUSSION 
 Malnutrition is recognized to be serious and common 
complication of CRF (4), and nutritional status is particularly 
important in children because it influences growth, sexual 
development and neurocognitive development (74, 75).   
 In this study 56 (86.1%) patients had malnutrition a 
comparable incidence (33.2%) was reported from Pakistan (12). 
 The incidence of renal failure was common in males 69% with 
a male to female ratio 2.2 : 1.  while in Tunisia M : F ratio was 1.83 
(87).  The predominance of males has been reported previously in 
Sudan (15-17).  This most likely due to increase incidence of urinary tract 
abnormalities seen in males. 
 In previous studies done by A. Rahman in 1998 and  Elnur 
2004, most patients were from the capital Khartoum 81 (28.8%) and  
30 (50%), respectively;  in contrast most of our patients were from 
northern and western states of country.  This could be related to the 
improvement of communication and referral system. 
 The majority of children in this study were irregular attendant  
or left school , this was in agreement with previous study done in 
Sudan (16,17) and with Lawrey et al (88) in which he showed that ESRD 
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patients tend to be below age and grade level in all areas whereas 
transplanted patients were achieving at or above level. 
 In over half of the patients the cause of renal failure in this 
study was undetermined  , glomerulonephritis was a cause in one 
sixth of the patients. This is  in contrast to other studies from the USA 
, France and Nottingham  in which they have shown that obstructive 
uropathy (12.5%), congenital nephropathies (86.5%) and renal 
dysplasia, hypoplasia (16.9%) were the commonest causes in this 
order  (89-91).  While in Tunisia the commonest causes leading to ESRD 
was hereditary nephropathy (28.4%) and chronic GN (16.4%) (87). 
 This difference could be due to the fact that most of our 
patients presented late, by the time when the kidneys were completely 
fibrosed and diagnosis could not be made by renal biopsy or other 
tools. 
 In this study half of the children with ESRD were on 
hemodialysis ,3 (4.6%) were on CAPD and 11 (6.9%) were on 
conservative management. In previous study done by Mohammed 
Babiker 2004 although most of patients were on hemodialysis 
(59.6%), CAPD was not introduced as modality of management, this 
could be due to improving awareness of CAPD as one of the good 
modality of management of CRF. 
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 There is a strong relationship between hemodialysis and 
malnutrition in this study, the regimen of inadequate dialysis was 
shown to have determinental effect on the child’s well being , growth 
and development (92). 
 ESRD was more common among the age group above 15 
years, this is similar to what was reported by  Elnur , where ESRD 
was more common among age group 10-15 years.  This is most likely 
due to increase life span and survival of our patients as child grows 
older, because of improved accessibility to specialized renal health 
and establishment of a lot of new renal centres for dialysis. 
 A substantial proportion of children with renal failure in our 
study developed growth impairment (height for age 67.7% and weight 
for age 86.1%) the mean height for age -2.8 SD and weight for age  
-2.5 SD. These results were comparable to the North American 
Paediatric Renal Transplantation Cooperative Study in which the 
mean height SDS of their patients before transplantation was more 
than -2.00 SDS (89). 
 This difference is likely to be attributed to the good facilities 
and strong adherent to dietary prescription in these centres, where’s 
that lost in our centres and the majority of children 24 (36.9%) were 
moderately malnourished, 20 (30.8%) were severely malnutrition and 
16 (24%) were normal, this result was obtained by using z-score 
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height for age SD; while nearly the same result obtained by using z-
score weight for age SD. 
 The severity of malnutrition increased significantly with 
duration of dialysis (P value < 0.017), malnutrition was also 
associated with hemodialysis (P value < 0.05) rather than peritoneal 
dialysis. 
 There was a high incidence of blood transfusion among the 
study group 54 (83.1%).  This could be attributed to the direct effect of 
the disease and poor adherence to medical management. 
 The most common presenting symptoms of malnutrition in the 
study group was weight loss; whereas skin pigmentation was the least 
presenting symptoms . 
 Dietary restriction of proteins was observed in one third of 
patient; this could be the reason to find a high percentage of a low 
total serum albumin among the study group 52 (80%) patients which 
may affect negatively and arrest progression of CRF and lead to 
malnutrition (73).  The mean duration of dialysis among the study 
group was 13 months with average of 1-4 months. There was 
significant relationship between duration on dialysis and development 
of malnutrition in the study group; this could be to the proven effect 
of dialysis as a contributing factor for developing malnutrition in 
children with CRF (65). 
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 Although no statistical significant relationship was found 
between malnutrition and classification of CRF; most patients of 
ESRD had malnutrition. 
 Three quarter of the families of patients in this study are of 
poor income.  This was similar to that  reported by  Abdel Raheem in 
2004.  this could have it’s negative impact on the expenses of 
medications and the development of malnutrition. 
 Adequate nutritional status can perhaps be defined as 
maintenance of normal pattern of growth and normal body 
composition by consumption of appropriate amounts and types of 
food (73). 
 Although it was recommended that consultation with dietitian 
should take place at least 3 times yearly and, in malnourished patient 
more often, as needed (3).  No dietitian clinic for patient of CRF 
established yet in Sudan. 
 Dietetic documentation should include reports of food intake, 
anthropometric measurement, estimation of serum albumin and 
prealbumin, the serum lipid profile, sodium and potassium intake, 
calcium and phosphorus status and any change in body weight (7).  
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Conclusions 
? The prevalence of malnutrition in children with CRF is very 
high . 
? The most common symptoms of malnutrition are weight loss 
followed by anorexia, lower limb swelling, night blindness and 
skin pigmentation. 
? Duration of hemodialysis was found to be strongly related to 
development of malnutrition. 
? No relation was found between family income per month and 
development of malnutrition. 
? CRF was common in rural areas and this is might be due to the 
early detection and presence of health services in this area. 
? Schooling of children of CRF was strongly affected by the 
disease.  
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Recommendations 
? The management of renal failure should be a multidisciplinary 
team approach.  Dietitions as well as social workers, 
psychologist and other team members should work together in 
nephrology units to lessen the complication. 
? Since malnutrition is a common complication; at least full 
anothropometric measurements as well as clinical and 
biochemical investigations should done for every patients 
attending the clinic of renal failure. 
? Dietary management should be an integral part of the 
management of CRF, so every child should be followed up by a 
dietition on a regular basis. 
? Effective renal transplantation program should be instituted in 
Sudan. 
? Due to the increasing number of children with CRF, adequately 
staff paediatric nephrology unit to be established in different 
regions of Sudan. 
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Figure 2:  Gender distribution of children with CRF
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